Liposomes as an ocular delivery system of fluconazole: in-vitro studies

被引:70
作者
Habib, Fawzia S. [2 ]
Fouad, Ehub A. [2 ]
Abdel-Rhaman, Mohamed S. [1 ]
Fathalla, Dina [2 ]
机构
[1] Assiut Univ, Dept Ophthalmol, Fac Med, Assiut, Egypt
[2] Assiut Univ, Fac Pharm, Dept Pharmaceut, Assiut, Egypt
关键词
Candida keratitis; fluconazole liposomal formulation; fluconazole solution; TOPICAL FLUCONAZOLE; CANDIDA-ALBICANS; KERATITIS; PENETRATION; FUNGAL;
D O I
10.1111/j.1755-3768.2009.01584.x
中图分类号
R77 [眼科学];
学科分类号
100212 [眼科学];
摘要
Purpose: To study the clinical effect of topical controlled-release ophthalmic fluconazole liposomal formulation and to compare its effect with fluconazole solution in a reproducible model of Candida keratitis in rabbits. Methods: Forty adult rabbits were included in this study. Right eyes were inoculated with freshly prepared Caindida albicans strain no. 4925 and showed signs of infected keratitis. The rabbits were divided randomly into two groups: in the first group (18 rabbits) the right eyes received fluconazole solution, while in the second group (22 rabbits) the right eyes received fluconazole-loaded liposomes. The rabbits' eyes were examined daily over a 21-day period and results were recorded. Results: Rabbits infected with C. albicans responded better and showed more improvement in terms of size of ulcer and hypopyon using fluconazole-loaded liposomal formulae than using fluconazole solution. In the first group (solution), nine rabbits' cornea showed complete healing (50%) at the end of third week while in group 2 (liposome), 19 rabbits' cornea showed complete healing (86.4%) at equal duration. These results were statistically significant. Conclusion: Therapy with topical liposomal fluconazole (2 mg/ml) was successful in eliminating experimental C. albicans infection of the rabbit cornea and was superior to fluconazole solution.
引用
收藏
页码:901 / 904
页数:4
相关论文
共 22 条
[1]
Penetration of topical fluconazole into human aqueous humor [J].
Abbasoglu, ÖE ;
Hosal, BM ;
Sener, B ;
Erdemoglu, N ;
Gürsel, E .
EXPERIMENTAL EYE RESEARCH, 2001, 72 (02) :147-151
[2]
Lipid-drug interaction: thermodynamic and structural effects of antimicotic fluconazole on DPPC liposomes [J].
Ambrosini, A ;
Bossi, G ;
Dante, S ;
Dubini, B ;
Gobbi, L ;
Leone, L ;
Bossi, MGP ;
Zolese, G .
CHEMISTRY AND PHYSICS OF LIPIDS, 1998, 95 (01) :37-47
[3]
[Anonymous], B OPHTHALMOL SOC EGY
[4]
TOPICAL FLUCONAZOLE FOR EXPERIMENTAL CANDIDA KERATITIS IN RABBITS [J].
BEHRENSBAUMANN, W ;
KLINGE, B ;
RUCHEL, R .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1990, 74 (01) :40-42
[5]
Characterization of a new ocular delivery system based on a dispersion of liposomes in a thermosensitive gel [J].
Bochot, A ;
Fattal, E ;
Grossiord, JL ;
Puisieux, F ;
Couvreur, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 162 (1-2) :119-127
[6]
DHARMA SK, 1986, ACTA OPHTHALMOL, V64, P298
[7]
Preparation and evaluation of acetazolamide liposomes as an ocular delivery system [J].
El-Gazayerly, ON ;
Hikal, AH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 158 (02) :121-127
[8]
Liposomes:: from biophysics to the design of peptide vaccines [J].
Frézard, F .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1999, 32 (02) :181-189
[9]
Goldblum D, 2005, ANTIMICROB AGENTS CH, V49, P1359, DOI 10.1128/AAC.49.4.1359-1363.2005
[10]
Vesicular systems in ocular drug delivery: an overview [J].
Kaur, IP ;
Garg, A ;
Singla, AK ;
Aggarwal, D .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 269 (01) :1-14